A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.
about
Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551.A phase I study of topotecan and gemcitabine in advanced solid tumors.Activity of topotecan 21-day infusion in patients with previously treated large cell lymphoma: long-term follow-up of an Eastern Cooperative Oncology Group study (E5493).Comeback for the camptothecins?Topotecan combined with Ifosfamide, Etoposide, and L-asparaginase (TIEL) regimen improves outcomes in aggressive T-cell lymphoma.
P2860
A phase II study of topotecan in non-Hodgkin's lymphoma: an Ohio State University phase II research consortium study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A phase II study of topotecan ...... II research consortium study.
@en
A phase II study of topotecan ...... II research consortium study.
@nl
type
label
A phase II study of topotecan ...... II research consortium study.
@en
A phase II study of topotecan ...... II research consortium study.
@nl
prefLabel
A phase II study of topotecan ...... II research consortium study.
@en
A phase II study of topotecan ...... II research consortium study.
@nl
P2093
P2860
P356
P1433
P1476
A phase II study of topotecan ...... II research consortium study.
@en
P2093
Donn Young
Eric H Kraut
Mellar P Davis
Ohio State University Phase II Reseeearch Consortium Study
Samuel A Jacobs
Stanley P Balcerzak
P2860
P304
P356
10.1081/CNV-120001143
P577
2002-01-01T00:00:00Z